We found that IL-15 levels were higher in the GL261, U251 and U87 glioma cells and primary cells BT-01 treated with Ad5-Ki67/IL-15 than in the control group after 24, 48, 72, and 96 h. The gene discussed is MKI67; the disease is glioma.